MX2016015759A - Estado de metilacion de adn como un biomarcador del consumo y abstinencia de alcohol. - Google Patents

Estado de metilacion de adn como un biomarcador del consumo y abstinencia de alcohol.

Info

Publication number
MX2016015759A
MX2016015759A MX2016015759A MX2016015759A MX2016015759A MX 2016015759 A MX2016015759 A MX 2016015759A MX 2016015759 A MX2016015759 A MX 2016015759A MX 2016015759 A MX2016015759 A MX 2016015759A MX 2016015759 A MX2016015759 A MX 2016015759A
Authority
MX
Mexico
Prior art keywords
abstinence
biomarker
dna methylation
methylation status
alcohol use
Prior art date
Application number
MX2016015759A
Other languages
English (en)
Inventor
Philibert Robert
Original Assignee
Philibert Robert
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philibert Robert filed Critical Philibert Robert
Publication of MX2016015759A publication Critical patent/MX2016015759A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6827Hybridisation assays for detection of mutation or polymorphism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2523/00Reactions characterised by treatment of reaction samples
    • C12Q2523/10Characterised by chemical treatment
    • C12Q2523/125Bisulfite(s)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/154Methylation markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Esta descripción proporciona métodos y materiales para determinar si un individuo consume o no alcohol, y también para determinar si el individuo ha dejado o no de consumir alcohol.
MX2016015759A 2014-05-30 2015-05-28 Estado de metilacion de adn como un biomarcador del consumo y abstinencia de alcohol. MX2016015759A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462005408P 2014-05-30 2014-05-30
PCT/IB2015/054041 WO2015181779A2 (en) 2014-05-30 2015-05-28 Dna methylation status as a biomarker of alcohol use and abstinence

Publications (1)

Publication Number Publication Date
MX2016015759A true MX2016015759A (es) 2017-06-06

Family

ID=54699995

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016015759A MX2016015759A (es) 2014-05-30 2015-05-28 Estado de metilacion de adn como un biomarcador del consumo y abstinencia de alcohol.

Country Status (14)

Country Link
US (1) US20170306405A1 (es)
EP (1) EP3149206B1 (es)
JP (1) JP6807833B2 (es)
KR (1) KR20170013921A (es)
CN (1) CN106661618B (es)
AU (1) AU2015265431B2 (es)
BR (1) BR112016028127A2 (es)
CA (1) CA2947128A1 (es)
ES (1) ES2827241T3 (es)
IL (1) IL248602A0 (es)
MX (1) MX2016015759A (es)
NO (1) NO20161786A1 (es)
SG (2) SG11201608817TA (es)
WO (1) WO2015181779A2 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201516972D0 (en) 2015-09-25 2015-11-11 Epiontis Gmbh LRP5 as epigenetic marker for the identification of immune cells, in particular B-cells
US11817214B1 (en) 2019-09-23 2023-11-14 FOXO Labs Inc. Machine learning model trained to determine a biochemical state and/or medical condition using DNA epigenetic data
US11795495B1 (en) 2019-10-02 2023-10-24 FOXO Labs Inc. Machine learned epigenetic status estimator

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010129354A2 (en) * 2009-04-28 2010-11-11 University Of Iowa Research Foundation Compositions and methods for detecting predisposition to a substance use disorder
GB201004147D0 (en) * 2010-03-12 2010-04-28 Dna Electronics Ltd Method and apparatus for sensing methylation
US20120149589A1 (en) * 2010-12-14 2012-06-14 Kent Hutchison Epigentic Markers Associated with Substance Use Disorders

Also Published As

Publication number Publication date
CN106661618A (zh) 2017-05-10
EP3149206B1 (en) 2020-09-02
KR20170013921A (ko) 2017-02-07
SG11201608817TA (en) 2016-11-29
US20170306405A1 (en) 2017-10-26
BR112016028127A2 (pt) 2017-08-22
WO2015181779A3 (en) 2016-03-10
WO2015181779A2 (en) 2015-12-03
EP3149206A2 (en) 2017-04-05
AU2015265431B2 (en) 2021-04-01
EP3149206A4 (en) 2017-11-15
JP2017518077A (ja) 2017-07-06
CA2947128A1 (en) 2015-12-03
ES2827241T3 (es) 2021-05-20
CN106661618B (zh) 2021-06-08
JP6807833B2 (ja) 2021-01-06
IL248602A0 (en) 2016-12-29
SG10201810760SA (en) 2018-12-28
NO20161786A1 (en) 2016-11-11
AU2015265431A1 (en) 2016-11-10

Similar Documents

Publication Publication Date Title
PH12020550781A1 (en) Anti-jagged1 antibodies and methods of use
PH12017500877A1 (en) ANTI-CD79b ANTIBODIES AND METHODS OF USE
PH12017500861A1 (en) Anti-interleukin-33 antibodies and uses thereof
MX2017005920A (es) Anticuerpos anti-tim3 y metodos de uso.
IL251261B (en) Reagents and methods for the identification, enrichment and/or expansion of antigen-specific T-cells
MX2019011911A (es) Procesos e compuestos intermedios en la preparacion de antagonistas de c5ar.
EP3201757A4 (en) Identifying temporal demand for autocomplete search results
EP3303636A4 (en) Companion methods and kits for il-2-based therapies and mesenchymal stem cell-based therapies
MX2016000997A (es) Metodos y composiciones para detectar contaminacion bacteriana.
EP3120129A4 (en) Core sample holder
MX2016009858A (es) Fusiones anti proteína convertasa subtilisina/kexina tipo 9 (anti-pcsk9)n péptido 1 similar a glucagón (glp-1) y métodos de uso.
EP3176268A4 (en) Novel biomarker for predicting sensitivity to egfr-targeting agent, and use thereof
MX2017005888A (es) Dispositivos, sistemas y metodos para la deteccion de analitos.
GB201620377D0 (en) Systems, methods, and kits for cleansing an ocular region
IL248598A0 (en) Foods, systems, methods and kits for providing electrolyte replacements
MX2016016233A (es) Anticuerpos anti-lgr5 y sus usos.
MX2016015759A (es) Estado de metilacion de adn como un biomarcador del consumo y abstinencia de alcohol.
EP4400600A3 (en) Methods for detecting multiple nucleic acids in a sample
EP3241909A4 (en) Pcr-rflp-based method for identifying, and determining the purity of piscirickettsia salmonis
EP3183574A4 (en) Beta lactamase as biomarker for the specific detection of tuberculosis-complex bacteria
EP3124500A4 (en) Anti-grpr antibody, method for producing same, detection method, use of the antibody, kit and gene construct
HUE049139T2 (hu) Rendszerek, módszerek és készletek a szem környékének tisztításához
GB2550625A (en) Identification of biological samples
NZ744340A (en) Anti-jagged1 antibodies and methods of use
EP3204407A4 (en) Novel tgf-alpha mutant proteins